Seeking Alpha

David Fry's  Instablog

David Fry
Send Message
David Fry writes a subscription newsletter focused on technical analysis of exchange-traded funds, called ETF Digest (www.etfdigest.com). Dave founded the ETF Digest in 2001 and was among the very first to see the need for a publication that provided individual investors with information and... More
My company:
ETF Digest
My blog:
Dave's Daily
My book:
The Best ETFs: U.S. Equities (A Companion Guide To Building Your ETF Portfolio)
  • ETF Close-Up: Nasdaq Biotechnology (IBB) 0 comments
    Jan 6, 2012 10:53 AM | about stocks: IBB

    david_gillie_rev

    David Gillie is a Contributing Editor and subscriber to the ETF Digest.

    He has been an Engineering Consultant for multi-million dollar construction claims, President and Founder of Envirospec, Inc. (Robotic Pipeline Inspection Equipment) and owner of David Gillie Woodworking & Design.

    He divides his time between Wilmington, North Carolina and Fort Myers, Florida.

     

     

     

    Huey Lewis wants "A New Drug"

    So does everybody else. 

    The problem is that it's a long and arduous process to bring a new drug to market. 

    Biotech/Pharma falls under the Health Care Sector which is considered a "defensive" sector. Yet, Biotech/Pharma is one of the highest risk industries.

     
    Stocks: IBB
Back To David Fry's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.